When it comes to cancer awareness campaigns, survivorship typically doesn’t get the same kind of attention as diagnosis and treatment. Merck & Co. wants to chang...

●       Innovative sensor monitors for sleep disorders from comfort of your own bedroom ●      &nb...

A week after Eli Lilly won an FDA emergency authorization for its COVID-19 antibody, concerns over limited supplies are already popping up, and the company is bringi...

Bristol Myers Squibb’s CAR-T dream, born from its $74 billion acquisition of Celgene, is thus far more of an agony than an ecstasy. The regulatory path for two key p...

With the COVID-19 pandemic nearing its second year in the U.S., lawmakers have banged the drum on boosting "onshore" production of key pharmaceuticals and ingre...

As Pfizer and Moderna dominate headlines with positive interim readouts for their COVID-19 vaccine candidates, other mRNA players are taking note. Ger...

Amarin's future with fish oil-derivative Vascepa looks rocky after the drugmaker's Hail Mary appeals to protect its flagship drug's patents fell flat. But even with ...

A week after Pfizer posted impressive early coronavirus vaccine efficacy numbers, Moderna took the spotlight early Monday with impressive findings of its own. But se...

AbbVie’s Venclyxto (venetoclax) has been recommended for use by the National Institute of Health and Care Excellence (NICE) as a routine treatment for chronic lympho...

ViiV Healthcare has announced that its long-acting injectable cabotegravir for HIV prevention demonstrated superiority compared to the current standard of treatment ...